Windlas Biotech Assets per Share

What does Windlas Biotech do? Windlas Biotech Ltd. generates revenue through its CDMO services, offering product discovery, development, licensing, and commercial manufacturing for generic and complex generic pharmaceuticals across therapeutic areas like anti-diabetic, cardiovascular, neuropsychiatry, and respiratory therapies. The company provides formulation development, technology scale-up, and full-scale manufacturing for solid and liquid dosage forms, serving clients in the pharmaceutical industry. Additionally, Windlas markets its own nutraceutical, pharmaceutical, and ayurvedic products through a salesforce and distribution network spanning over 14 states, targeting semi-urban and rural communities. Its manufacturing facilities in Dehradun support both CDMO operations and in-house product production. The company's primary clients for CDMO services are pharmaceutical firms seeking development and manufacturing solutions for generic drugs. These clients benefit from Windlas's capabilities in formulation development, scale-up, and commercial production. The firm's own product line, sold via its distribution network, reaches semi-urban and rural consumers in India, complementing its CDMO business. Manufacturing in Dehradun enables efficient production for both external clients and internal product lines. Windlas Biotech's revenue streams include contract manufacturing for pharmaceutical companies and direct sales of its branded nutraceutical, pharmaceutical, and ayurvedic products. The CDMO segment focuses on complex generics in key therapeutic categories, while the in-house product line targets underserved communities with accessible healthcare solutions. The dual approach leverages the company's manufacturing infrastructure to serve both business-to-business and business-to-consumer markets. Windlas Biotech is one of the most popular companies on Eulerpool.